Abin sarrafawa
Sinadaran mai aiki: Mazdoride
Samfara
1.Dal -} niyya AGONIst:
Dual agonists na GLP {{1} 1 receptor (Glucagon-kamar Peptide-1) da GCGR Mai Tasri (Gcgang Mai Tsaro (GCCagon Receptor).
2.Dications:
Jinin glucose na jini a cikin nau'in sukari na 2 na ƙwayar cuta (T2DM)
Komawa / Gudanar da Gudanar da (da aka yarda da su a wasu ƙasashe ko yankuna)
Tsarin magunguna:
Mazdutide ya ci nasara sakamakon warkewa ta hanyar ayyukan da suka biyo baya:
1.glp-1 Kunna Kunnen Stagation: Inganta m indultion, yana hana glucagon saki, da kuma yowers sukari jini. Jinkirta gastric shafe da ƙara jin wani yanayi.
2.Gcgr Receptor Kunna: Ingancin kashe kudi, yana inganta mai metabolism, kuma yana inganta glucleogenesis.
Falmwa samfurin:
Na'urori 1. Idan aka kwatanta da magunguna guda 1 (kamar semaglututide), ƙarin kunnawar kunna GcGr na iya kawo ƙarin sakamako mai nauyi da tasirin rayuwa.
2. Dogon tsayi {{1} {Esturearfin Lokaci
3. Cikakken fa'idodi na metabolisi fa'idodi: ban da rage yawan sukari na jini, zai iya rage lipids na jini, da kuma inganta rashin biyan saurin hanjin (nahld), da sauransu), da sauransu), da sauransu.
4. Tasirin hypoglycemic: a cikin marasa lafiya da nau'in ciwon sukari na 2, hemoglobin) yana raguwa sosai (gwaji na asibiti yana nuna raguwar 1.5% zuwa 2.0%).
5. Sakamakon asarar nauyi: Matsakaicin nauyi don marasa lafiya naƙi na iya kaiwa 10% zuwa 15% (babba - {Kungiyar Rako).
6. Kayayyakin: Rashin daidaituwa
Hot Tags: Babban {{0- asarar nauyi acture Peptde, China High- en rasa masana'antar nauyi peptide mazadawa